These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17530621)

  • 1. Diagnosing Alzheimer's disease--non-clinicians and computerised algorithms together are as accurate as the best clinical practice.
    Foy CM; Nicholas H; Hollingworth P; Boothby H; Willams J; Brown RG; Al-Sarraj S; Lovestone S
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1154-63. PubMed ID: 17530621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease.
    Piguet O; Halliday GM; Creasey H; Broe GA; Kril JJ
    Int Psychogeriatr; 2009 Aug; 21(4):688-95. PubMed ID: 19493380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can clock drawing differentiate Alzheimer's disease from other dementias?
    Tan LP; Herrmann N; Mainland BJ; Shulman K
    Int Psychogeriatr; 2015 Oct; 27(10):1649-60. PubMed ID: 26138809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
    Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT
    Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach.
    Hogervorst E; Bandelow S; Combrinck M; Irani SR; Smith AD
    Dement Geriatr Cogn Disord; 2003; 16(3):170-80. PubMed ID: 12826744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias.
    Simonsen AH; Mattila J; Hejl AM; Garde E; van Gils M; Thomsen C; Lötjönen J; Soininen H; Waldemar G
    Dement Geriatr Cogn Disord; 2014; 37(3-4):207-13. PubMed ID: 24193095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
    Herbert MK; Aerts MB; Kuiperij HB; Claassen JAHR; Spies PE; Esselink RAJ; Bloem BR; Verbeek MM
    Alzheimers Dement; 2014 Jul; 10(4):448-455.e2. PubMed ID: 24239248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
    Chaudhry A; Houlden H; Rizig M
    J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
    Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
    Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of QOL between patients with different degenerative dementias, focusing especially on positive and negative affect.
    Kurisu K; Terada S; Oshima E; Horiuchi M; Imai N; Yabe M; Yokota O; Ishihara T; Yamada N
    Int Psychogeriatr; 2016 Aug; 28(8):1355-61. PubMed ID: 27020694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
    Walker MP; Ayre GA; Cummings JL; Wesnes K; McKeith IG; O'Brien JT; Ballard CG
    Neurology; 2000 Apr; 54(8):1616-25. PubMed ID: 10762503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.
    Binnewijzend MA; Kuijer JP; van der Flier WM; Benedictus MR; Möller CM; Pijnenburg YA; Lemstra AW; Prins ND; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Eur Radiol; 2014 Sep; 24(9):2326-33. PubMed ID: 24996793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.
    Morimoto S; Takao M; Hatsuta H; Nishina Y; Komiya T; Sengoku R; Nakano Y; Uchino A; Sumikura H; Saito Y; Kanemaru K; Murayama S
    PLoS One; 2017; 12(2):e0171524. PubMed ID: 28166276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.
    Garn H; Coronel C; Waser M; Caravias G; Ransmayr G
    J Neural Transm (Vienna); 2017 May; 124(5):569-581. PubMed ID: 28243755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.
    Mitolo M; Hamilton JM; Landy KM; Hansen LA; Galasko D; Pazzaglia F; Salmon DP
    J Int Neuropsychol Soc; 2016 Jul; 22(6):609-19. PubMed ID: 27221597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical dementia: when it is not Alzheimer's disease.
    Bhidayasiri R
    J Med Assoc Thai; 2007 Oct; 90(10):2222-32. PubMed ID: 18041446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.
    Blanc F; Mahmoudi R; Jonveaux T; Galmiche J; Chopard G; Cretin B; Demuynck C; Martin-Hunyadi C; Philippi N; Sellal F; Michel JM; Tio G; Stackfleth M; Vandel P; Magnin E; Novella JL; Kaltenbach G; Benetos A; Sauleau EA
    Alzheimers Res Ther; 2017 Jun; 9(1):47. PubMed ID: 28655337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.